Answers are grounded in this paper and cite their sources.
Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor that regulates fatty acid transport and metabolism. Previous studies revealed that PPARα can affect bile acid metabolism; however, the mechanism by which PPARα regulates bile acid homeostasis is not understood. In this study, an ultraperformance liquid chromatography coupled with electrospray ionization qua dru pole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS)-based metabolomics approach was used to profile metabolites in urine, serum, and bile of wild-type and Ppara-null mice following cholic acid (CA) dietary challenge. Metabolomic analysis showed that the levels of several serum bile acids, such as CA (25-fold) and taurocholic acid (16-fold), were significantly increased in CA-treated Ppara-null mice compared with CA-treated wild-type mice. Phospholipid homeostasis, as revealed by decreased serum lysophos phati dylcholine (LPC) 16:0 (1.6-fold) and LPC 18:0 (1.6-fold), and corticosterone metabolism noted by increased urinary excretion of 11β-hydroxy-3,20-dioxopregn-4-en-21-oic acid (20-fold) and 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid (3.6-fold), were disrupted in CA-treated Ppara-null mice. The hepatic levels of mRNA encoding transporters Abcb11, Abcb4, Abca1, Abcg5, and Abcg8 were diminished in Ppara-null mice, leading to the accumulation of bile acids in the liver during the CA challenge. These observations revealed that PPARα is an essential regulator of bile acid biosynthesis, transport, and secretion. Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor that regulates fatty acid transport and metabolism. Previous studies revealed that PPARα can affect bile acid metabolism; however, the mechanism by which PPARα regulates bile acid homeostasis is not understood. In this study, an ultraperformance liquid chromatography coupled with electrospray ionization qua dru pole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS)-based metabolomics approach was used to profile metabolites in urine, serum, and bile of wild-type and Ppara-null mice following cholic acid (CA) dietary challenge. Metabolomic analysis showed that the levels of several serum bile acids, such as CA (25-fold) and taurocholic acid (16-fold), were significantly increased in CA-treated Ppara-null mice compared with CA-treated wild-type mice. Phospholipid homeostasis, as revealed by decreased serum lysophos phati dylcholine (LPC) 16:0 (1.6-fold) and LPC 18:0 (1.6-fold), and corticosterone metabolism noted by increased urinary excretion of 11β-hydroxy-3,20-dioxopregn-4-en-21-oic acid (20-fold) and 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid (3.6-fold), were disrupted in CA-treated Ppara-null mice. The hepatic levels of mRNA encoding transporters Abcb11, Abcb4, Abca1, Abcg5, and Abcg8 were diminished in Ppara-null mice, leading to the accumulation of bile acids in the liver during the CA challenge. These observations revealed that PPARα is an essential regulator of bile acid biosynthesis, transport, and secretion. apical sodium-dependent bile salt transporter alanine aminotransferase alkaline phosphatase bile acid-CoA synthetase bile acid-CoA amino acid N-acetyltransferase blood urea nitrogen cholic acid chenodeoxycholic acid cytochrome P450 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid ectonucleotide pyrophosphatase/phosphodiesterase 2 farnesoid X receptor 11β 20-dioxopregn-4-en-21-oic acid hydroxy-delta-5-steroid dehydrogenase lysophosphatidylcholine lysophosphatidylcholine acyltransferase lysophospholipase A1 organic anion transporter organic anion transporting polypeptide 1 sodium-taurocholate cotransporting polypeptide organic cation transporter peroxisome proliferator-activated receptor α principal component analysis retention time solute carrier family taurocholic acid taurochenodeoxycholic acid tauro-α/β-muricholic acid taurodeoxycholic acid tauromurideoxycholic acid tumor necrosis factor α tauroursodeoxycholic acid ultraperformance liquid chromatography-electrospray ionization-quadrupole time-of-flight mass spectrometry 643, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid Peroxisome proliferator-activated receptor α (PPARα) is a nuclear hormone receptor regulating genes involved in lipid homeostasis, including fatty acid transport and catabolism, lipoprotein metabolism, glucose homeostasis, and inflammation (1Inagaki T. Dutchak P. Zhao G. Ding X. Gautron L. Parameswara V. Li Y. Goetz R. Mohammadi M. Esser V. et al.Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.Cell Metab. 2007; 5: 415-425Abstract Full Text Full Text PDF PubMed Scopus (1186) Google Scholar, 2Mandard S. Muller M. Kersten S. Peroxisome proliferator-activated receptor alpha target genes.Cell. Mol. Life Sci. 2004; 61: 393-416Crossref PubMed Scopus (802) Google Scholar). Recent studies have suggested a role for PPARα in bile acid biosynthesis. A previous study reported that the expression level of cholesterol 7α-hydroxylase (Cyp7a1) and 8β-hydroxylase (Cyp8b1) was upregulated in wild-type mice during [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) treatment and fasting conditions; this effect was diminished in Ppara-null mice, thus revealing the involvement of PPARα (3Hunt M.C. Yang Y.Z. Eggertsen G. Carneheim C.M. Gafvels M. Einarsson C. Alexson S.E. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis.J. Biol. Chem. 2000; 275: 28947-28953Abstract Full Text Full Text PDF PubMed Scopus (137) Google Scholar). Another study found that both human CYP7A1 and mouse Cyp7a1 promoters were stimulated by fatty acids and Wy-14,643 treatment (4Cheema S.K. Agellon L.B. The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha.J. Biol. Chem. 2000; 275: 12530-12536Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar). These studies provided compelling evidence that PPARα can positively regulate bile acid biosynthesis. In contrast to the above observations, it was reported that 0.5% bezafibrate treatment leads to a decrease in liver bile acid and Cyp7a1 expression in wild-type mice and Ppara-null mice (5Hays T. Rusyn I. Burns A.M. Kennett M.J. Ward J.M. Gonzalez F.J. Peters J.M. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.Carcinogenesis. 2005; 26: 219-227Crossref PubMed Scopus (110) Google Scholar). Others found that Cyp7a1 and cholesterol 27α-hydroxylase (Cyp27a1) were decreased in wild-type mice by ciprofibrate treatment but not in Ppara-null mice (6Post S.M. Duez H. Gervois P.P. Staels B. Kuipers F. Princen H.M. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1840-1845Crossref PubMed Scopus (171) Google Scholar). These results indicate that the activation of PPARα by fibrates can inhibit bile acid biosynthesis; however, bezafibrate and ciprofibrate show different effects on bile acid biosynthesis enzymes in Ppara-null mice. Thus, the mechanism by which PPARα controls bile acid homeostasis remains uncertain. Additionally, limited studies revealed that PPARα exert its effect on the bile acid conjugation and transport in the liver and intestine (7Cheng X. Klaassen C.D. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.Toxicol. Sci. 2008; 106: 37-45Crossref PubMed Scopus (42) Google Scholar, 8Jung D. Fried M. Kullak-Ublick G.A. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha.J. Biol. Chem. 2002; 277: 30559-30566Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar). Recent studies have the of mass metabolomics to profile to the mechanism of of nuclear and the of Y. C. Gonzalez F.J. Metabolomic and analysis of for peroxisome proliferator-activated receptor alpha expression and 2007; 21: PubMed Scopus Google F. Gonzalez F.J. metabolism of and in the mouse PubMed Scopus Google Scholar). revealed the following Wy-14,643 treatment Y. C. Gonzalez F.J. Metabolomic and analysis of for peroxisome proliferator-activated receptor alpha expression and 2007; 21: PubMed Scopus Google and the decreased excretion of metabolites by treatment in Li F. F. Gonzalez F.J. Human urinary profile of fatty acid PubMed Scopus Google Scholar). an in the excretion of metabolites was in Ppara-null mice Y. C. Gonzalez F.J. Metabolomic and analysis of for peroxisome proliferator-activated receptor alpha expression and 2007; 21: PubMed Scopus Google and the fatty acid including and were in the serum of PPARα by C. Gonzalez F.J. metabolomics of fatty acid the of activation as a mechanism of PubMed Scopus Google Scholar). In the study, cholic acid wild-type and Ppara-null mice were used to the role of PPARα in bile acid analysis showed that liver in Ppara-null mice was during CA including the of bile acids, and cholesterol Additionally, the excretion of several and metabolites was significantly results that PPARα a role in bile acid homeostasis via regulation of bile acid biosynthesis, transport, and secretion. acid taurocholic acid chenodeoxycholic acid tauro-α/β-muricholic acid taurochenodeoxycholic acid taurodeoxycholic acid tauroursodeoxycholic acid tauromurideoxycholic acid and were acid and 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid were and were and organic were of the Ppara-null mice and wild-type mice on a were a with and a provided was in with an study by the and of to mice were on a for Ppara-null mice and wild-type mice were with CA with and for on previous studies M. M. Ward J.M. G. Gonzalez F.J. of the nuclear receptor bile acid and lipid 2000; Full Text Full Text PDF PubMed Scopus Google P. Y. Klaassen C.D. of bile acids on serum and liver bile and in Sci. PubMed Scopus Google Scholar). were and was mice in for and on and following the The mice to and in were The serum, and were and for analysis the of the for were by with were by serum with and bile were by 1 bile with The were for in and for to and The was to an for A of was the of ultraperformance liquid chromatography coupled time-of-flight mass The liquid chromatography was of a with a acid and acid The was A for increased to the and to A in 2 were in and on a which was in to was used as both and and were and The and were and was in the as the were to a of to a and retention time the of a this was for principal component analysis The and the were used to the in Ppara-null mice compared with mice. the of metabolomics and were to T. for of by mass 2007; PubMed Scopus Google were used to the mass on the of the of to in were compared with the and serum on the of with to V. of the were by of and retention time with of metabolites in and serum was an coupled with a mass The and of were by mass The following were for acid CA LPC 16:0 and LPC 18:0 The of metabolites in and serum were by of with the of was used as the was of liver and was in an are in the I. mRNA levels were to of and as to of wild-type mice a alanine aminotransferase alkaline phosphatase and serum were the were in and to in different of and for were the were a and are as analysis was The of and mRNA levels was the with for of were wild-type and Ppara-null mice a showed in Ppara-null mice a CA for wild-type mice were decreased were in and the of mice analysis showed fatty liver and in CA-treated Ppara-null mice In fatty liver and was in wild-type mice the CA that the lipid of hepatic in CA-treated Ppara-null mice was cholesterol and In serum analysis that CA-treated Ppara-null mice showed and serum levels CA-treated wild-type mice These results indicate that Ppara-null mice are to liver by dietary CA and serum mass mass of wild-type and Ppara-null mice with CA The of was by the to the The mass was by the liver to the in a of wild-type and Ppara-null mice with CA The of was by the to the The mass was by the liver to the an for Ppara-null mice were to CA wild-type mice, analysis was used to profile the metabolites in the serum, urine, and bile the was used to the the and in both wild-type and Ppara-null mice. The that bile wild-type and Ppara-null mice with CA were in different CA can significantly bile in both wild-type and Ppara-null mice however, were in bile wild-type and Ppara-null mice CA-treated wild-type and Ppara-null mice These suggested that different bile were in the of mice of and serum were in the CA-treated and on with the a was CA-treated Ppara-null and wild-type mouse serum in component 1 of the that serum metabolites were by CA treatment in Ppara-null of and serum metabolites significantly in mice with CA treatment of a and of urinary wild-type and mice with CA for an mouse and a urinary metabolites are in the (1Inagaki T. Dutchak P. Zhao G. Ding X. Gautron L. Parameswara V. Li Y. Goetz R. Mohammadi M. Esser V. et al.Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.Cell Metab. 2007; 5: 415-425Abstract Full Text Full Text PDF PubMed Scopus (1186) Google X. Klaassen C.D. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.Toxicol. Sci. 2008; 106: 37-45Crossref PubMed Scopus (42) Google Scholar). of an and of serum wild-type and mice with CA for an mouse serum and a serum metabolites are in the D. Fried M. Kullak-Ublick G.A. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha.J. Biol. Chem. 2002; 277: 30559-30566Abstract Full Text Full Text PDF PubMed Scopus (95) Google C. Gonzalez F.J. metabolomics of fatty acid the of activation as a mechanism of PubMed Scopus Google Scholar). The and to principal 1 and The the and the of the were in serum were in of wild-type and Ppara-null mice in the and a revealed with the to Ppara-null mice and The increased in Ppara-null mice CA were in the and and decreased in the and the that to the mass of were used for and in metabolomics and The and in to and The and in serum to LPC and LPC 18:0 of in CA-treated Ppara-null mice compared with CA-treated wild-type in a Metabolomic analysis that was the increased in the serum of Ppara-null mice. The level of was increased of and the was of treatment in Ppara-null mice compared with wild-type mice with CA was in Ppara-null mice to was a in CA-treated Ppara-null mice compared with CA-treated wild-type mice. In the levels of serum and were increased of treatment in Ppara-null mice with CA gene expression analysis that the enzymes involved in the bile acid biosynthesis, including and hydroxy-delta-5-steroid dehydrogenase were decreased in the Ppara-null mice of treatment compared with CA-treated wild-type mice and Ppara-null mice enzymes involved in the bile acid bile acid-CoA synthetase and bile acid-CoA amino acid N-acetyltransferase were significantly diminished in the liver of Ppara-null mice. The bile acid transporters sodium-taurocholate cotransporting polypeptide anion transporting polypeptide 1 and anion transporting polypeptide which bile acids blood were decreased in Ppara-null mice, the transporter which bile acids liver to was increased In the mRNA encoding bile acid transporter in liver that bile acids liver to bile was increased by CA treatment in wild-type and Ppara-null mice. levels of were in CA-treated Ppara-null mice compared with CA-treated wild-type mice. Metabolomic analysis of bile that CA treatment significantly the bile acid of bile in both wild-type and Ppara-null mice, and CA treatment significantly the bile in both wild-type and Ppara-null mice, the of bile acids in bile were compared with CA-treated wild-type mice, and were in CA-treated Ppara-null mice. These results suggested that the bile acid homeostasis was disrupted in CA-treated Ppara-null mice compared with CA-treated wild-type mice and mice. with the accumulation of bile acids, analysis showed the decreased levels of LPC 16:0 and LPC 18:0 in the serum of CA-treated Ppara-null mice. that the level of LPC 16:0 was decreased in CA-treated Ppara-null mice to with LPC the level of LPC 18:0 was significantly in CA-treated Ppara-null mice on was a of both in CA-treated Ppara-null mice compared with CA-treated wild-type mice. have reported to for T. Gonzalez F.J. acid and homeostasis leading to in PubMed Scopus Google Scholar). gene expression that the encoding enzymes involved in the LPC biosynthesis acyltransferase 1 1 and were significantly decreased in CA-treated Ppara-null mice compared with CA-treated wild-type mice and Ppara-null mice the expression of encoding with LPC metabolism acyltransferase lysophospholipase A1 and ectonucleotide 2 were in CA-treated Ppara-null mice In the mRNA encoding the transporter in the liver was diminished in CA-treated Ppara-null mice compared with CA-treated wild-type mice. These indicate that homeostasis was disrupted in CA-treated Ppara-null mice. The of bile acids cholesterol is a for cholesterol in cholesterol were the metabolites with cholesterol and hormone metabolism were in serum and was in serum corticosterone and levels corticosterone and showed a in of CA-treated Ppara-null mice metabolites were significantly increased to and were increased by and in CA-treated Ppara-null mice compared with CA-treated wild-type mice. In hepatic expression levels of the PPARα target gene family was significantly diminished in the Ppara-null mice compared with wild-type mice T. T. Y. T. T. S. et of acid synthesis by peroxisome proliferator-activated receptor alpha and role of the Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The mRNA encoding involved in the of and was increased in CA-treated Ppara-null mice genes with corticosterone metabolism, such as family 1 dehydrogenase and dehydrogenase family were decreased These suggested that expression was for the of and in the CA-treated Ppara-null mice In cholesterol A 1 and were significantly decreased in CA-treated Ppara-null mice compared with CA-treated wild-type mice. the mRNA levels of and Abcg8 are by CA treatment in wild-type mice, was CA-treated and Ppara-null mice. with the in the and analysis revealed levels of and such as and in of CA-treated Ppara-null mice. in the excretion of was significantly decreased in CA-treated Ppara-null mice. the level of urinary metabolites was as mass in The excretion of was significantly increased in CA-treated Ppara-null mice to excretion was decreased on The excretion of cation was significantly to the urinary excretion of anion and acid was decreased in CA-treated Ppara-null mice on analysis that the expression of several organic cation transporters and organic anion transporters was diminished in the liver and of CA-treated Ppara-null mice compared with Ppara-null mice and CA-treated wild-type mice, including organic cation transporter 1 organic cation transporter 2 organic cation transporter organic transporter 1 organic transporter 2 and and These results that CA leads to a of cation and anion transport in Ppara-null mice. the role of PPARα in bile acid homeostasis, the study the in metabolites and genes in Ppara-null mice during to a CA of bile acid homeostasis, homeostasis, cholesterol metabolism, and and transport in CA-treated Ppara-null mice. gene expression analysis revealed that the bile acid in CA-treated Ppara-null mice to a in expression of the transporters Abcb4, Abca1, Abcg5, and in the liver Additionally, the levels of bile acid synthesis enzymes and were in Ppara-null mice in wild-type mice. These results that PPARα regulates bile acid homeostasis not via its effect on bile acid biosynthesis and transport but via its effect on secretion. Ppara-null mice were with a CA was liver The in of the CA-treated Ppara-null mice serum and and These are with reported for the farnesoid X receptor mice CA T. H. Gonzalez F.J. metabolomics in mice bile acid Full Text Full Text PDF PubMed Scopus Google Scholar). In and glucose levels were in Ppara-null mice. analysis revealed an of bile acid metabolism, metabolism, and cholesterol metabolism, in CA-treated Ppara-null mice. a level of bile acids, including and were noted in CA-treated Ppara-null mouse serum, and the genes involved in bile acid synthesis and transport were diminished in the thus liver Ppara-null mice studies have that increased levels of serum bile acids were in S. M. role of activation and in cholic acid-induced 2007; PubMed Scopus Google Scholar, S. C. S. B. G. G. D. et effects of chenodeoxycholic a farnesoid X receptor in 2005; PubMed Scopus Google Scholar, M. Kuipers F. F. et bile salt in with Full Text Full Text PDF PubMed Scopus Google Scholar). LPC 16:0 and LPC were decreased in CA-treated Ppara-null mice which are by are the in are in bile that are to liver bile acid In the levels of serum are with liver Zhao X. X. C. P. Li L. Yang S. G. liquid spectrometry for for of liver in 5: PubMed Scopus Google Scholar, P. D. Zhao C. Zhao X. X. Yang S. G. A study of liver and by and coupled with mass 5: PubMed Scopus Google Scholar). it was reported that a of were significantly decreased in by treatment and by and treatment T. Gonzalez F.J. acid and homeostasis leading to in PubMed Scopus Google Scholar, F. of and bile acid homeostasis in mice with of Scholar). the excretion of and was increased in the CA-treated Ppara-null mice and were corticosterone the effect of cytochrome which was by in and in Y. C. Gonzalez F.J. Metabolomic and analysis of for peroxisome proliferator-activated receptor alpha expression and 2007; 21: PubMed Scopus Google Scholar, T. T. Y. T. T. S. et of acid synthesis by peroxisome proliferator-activated receptor alpha and role of the Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). and were reported as for PPARα activation Y. C. Gonzalez F.J. Metabolomic and analysis of for peroxisome proliferator-activated receptor alpha expression and 2007; 21: PubMed Scopus Google Scholar). the expression of PPARα target genes in Ppara-null mice suggested that the in both metabolites in this study was not to the activation of was reported that in and the can by and such as tumor necrosis factor α in the of M. necrosis in Google Scholar). studies that the excretion of and was increased in the of nuclear factor mice Gonzalez F.J. in PubMed Scopus Google and CA-treated mice T. H. Gonzalez F.J. metabolomics in mice bile acid Full Text Full Text PDF PubMed Scopus Google Scholar). the expression of was in CA-treated Ppara-null mice, that corticosterone metabolism in CA-treated Ppara-null mice results liver The in the bile acids, and cholesterol homeostasis compelling evidence that was in Ppara-null mice in response to CA challenge. Another in this study is the disrupted transport of and in the liver and The that levels of and in the CA-treated Ppara-null mice is to of in In the liver and the family the and excretion of including and and and Y. Y. D. S. T. T. T. T. M. et and analysis of cation transporter PubMed Scopus Google Scholar). studies have that an role in of in and mice Y. M. transport by organic cation transporter in the human 2004; 21: PubMed Scopus Google Scholar, G. H. V. D. Yang et of by organic cation transporter in PubMed Scopus Google Scholar). Additionally, used as a for organic cation transport, can regulated by and C. and expression of a mouse liver organic cation PubMed Scopus Google Scholar, Y. M. S. H. and of organic cation and of Google Scholar). In and are These studies that of affect the transport of and in Additionally, organic and were significantly decreased in CA-treated Ppara-null mice. A study metabolomics revealed that both metabolites were as with the of S.K. metabolomics metabolites and as of organic anion transporter 1 PubMed Scopus Google Scholar). Another study by spectrometry that the excretion of organic was decreased in mouse V. M. T. J.M. et organic anion and accumulation of organic in Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). CA treatment decreased and in Ppara-null mouse liver and mRNA is found in X. S. B. et of an organic anion transport in liver and Google including the and is in the liver V. B. L. B. of organic anion transporting polypeptide in liver and of its with and 2001; PubMed Scopus Google Scholar). with the transport of bile acids, both transporters a role in the uptake and of organic in the and such as and V. B. B. R. of organic anion transporting polypeptide as a of the in 2000; PubMed Scopus Google Scholar, P. of the bile is mediated by and 2002; PubMed Scopus Google Scholar). Thus, it is that the diminished expression of and in the liver and is for the decrease of and acid in Previous studies have that the of PPARα can affect bile acid biosynthesis. different such as Wy-14,643 and show different effects on the in bile acid synthesis Cyp7a1 with and Wy-14,643 is a of for different effects is that the level of Cyp7a1 regulated by nuclear such as liver X receptor S. fatty acid and cholesterol metabolism mediated by liver X 2000; PubMed Scopus Google and nuclear factor during the activation of PPARα The effect of receptor-alpha on the of the cholesterol 2000; PubMed Scopus Google Scholar, M. Peroxisome proliferator-activated receptor alpha (PPARalpha) and inhibit cholesterol 7alpha-hydroxylase gene 2000; Full Text Full Text PDF PubMed Google Scholar). In this study, in with wild-type mice, the enzymes involved in biosynthesis of bile acids cholesterol were in Ppara-null mice, including and study reported that the mRNA level of Cyp7a1 in Ppara-null mice compared with wild-type mice (3Hunt M.C. Yang Y.Z. Eggertsen G. Carneheim C.M. Gafvels M. Einarsson C. Alexson S.E. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis.J. Biol. Chem. 2000; 275: 28947-28953Abstract Full Text Full Text PDF PubMed Scopus (137) Google Scholar). studies showed that ciprofibrate T. H. R. Staels B. Kuipers F. Peroxisome proliferator-activated receptor alpha regulation of 2 expression and in PubMed Scopus Google and fatty acids (7Cheng X. Klaassen C.D. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.Toxicol. Sci. 2008; 106: 37-45Crossref PubMed Scopus (42) Google a decrease in hepatic transporters and the level of and were in Ppara-null mice compared with wild-type mice. In the the expression of was decreased in Ppara-null mice, with the observations that Ppara-null mice show hepatic level wild-type mice (5Hays T. Rusyn I. Burns A.M. Kennett M.J. Ward J.M. Gonzalez F.J. Peters J.M. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.Carcinogenesis. 2005; 26: 219-227Crossref PubMed Scopus (110) Google Scholar). Thus, the of PPARα can affect the bile acid transporter in the the mRNA levels of the transporter and cholesterol transporters Abca1, Abcg5, and Abcg8 were diminished in the liver following of studies have that treatment with Wy-14,643 and PPARα can the expression of Abcb4, Abca1, Abcg5, and Abcg8 T. H. R. Staels B. Kuipers F. Peroxisome proliferator-activated receptor alpha regulation of 2 expression and in PubMed Scopus Google G. S. V. B. M. et and cholesterol human of the 2001; PubMed Scopus Google Scholar). it was reported that PPARα can regulate hepatic lipid homeostasis via its target effect on transporters M. M. R. C. Muller M. Kersten S. analysis of regulation of hepatic lipid metabolism by expression 2007; PubMed Scopus (171) Google Scholar, M. B. Muller M. Kersten S. Peroxisome proliferator-activated receptor alpha target 61: Scholar). CA the mRNA expression of transporters the transport of bile acids in Ppara-null mice, liver the of PPARα can decreased bile acid biosynthesis, transport, and secretion. the expression of several genes involved in the bile acid metabolism was in Ppara-null mice, metabolomics not bile acid levels in and serum in mice. the role of PPARα in the regulation of bile acid homeostasis, CA was in Ppara-null mice. The results showed in Ppara-null mice during CA that was not in wild-type mice. studies have reported that CA can to liver in mice in which genes involved in bile acid metabolism such as mice M. H. T. Gonzalez F.J. Y. Role of farnesoid X receptor in the of bile acid and excretion of bile a mechanism for cholic acid-induced liver 2005; PubMed Scopus Google mice R. P. L. D. D. M.J. V. by cholic acid in mice of of PubMed Scopus Google and mice L. D. Y. S. P. M. et for regulation of bile acid 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). The studies a role of PPARα in the regulation of bile acid The in CA-treated Ppara-null mice to the decrease in expression of the transporters in the liver The the accumulation of bile acids in Ppara-null mice liver during CA a was in CA-treated Ppara-null by including bile acid metabolism, metabolism, cholesterol metabolism, and transport of and The the of mass analysis in with serum analysis and a mouse to profile and the of nuclear
No takes yet. Share an insight, caveat, or question.
Li et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: